Literature DB >> 26622097

Irreversible Electroporation.

Govindarajan Narayanan1.   

Abstract

Irreversible electroporation (IRE) is a predominantly nonthermal ablative technology that uses high-voltage, low-energy DC current pulses to induce cell death. Thermal ablative technologies such as radiofrequency ablation, microwave ablation, and cryoablation have several applications in oncology but have limitations that have been established. IRE has shown promise to overcome some of these limitations. This article reviews the basics of the technology, patient selection, clinical applications, practical pointers, and the published data.

Entities:  

Keywords:  ablation; interventional radiology; irreversible electroporation; liver; pancreas; prostate

Year:  2015        PMID: 26622097      PMCID: PMC4640920          DOI: 10.1055/s-0035-1564706

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  17 in total

1.  Cancer cells ablation with irreversible electroporation.

Authors:  Liron Miller; Jonathan Leor; Boris Rubinsky
Journal:  Technol Cancer Res Treat       Date:  2005-12

2.  In vivo results of a new focal tissue ablation technique: irreversible electroporation.

Authors:  Jon F Edd; Liana Horowitz; Rafael V Davalos; Lluis M Mir; Boris Rubinsky
Journal:  IEEE Trans Biomed Eng       Date:  2006-07       Impact factor: 4.538

3.  Irreversible electroporation: implications for prostate ablation.

Authors:  Gary Onik; Paul Mikus; Boris Rubinsky
Journal:  Technol Cancer Res Treat       Date:  2007-08

4.  Irreversible electroporation in medicine.

Authors:  Boris Rubinsky
Journal:  Technol Cancer Res Treat       Date:  2007-08

Review 5.  Optimum chemotherapy in the management of metastatic pancreatic cancer.

Authors:  Marwan Ghosn; Hampig Raphael Kourie; Fadi El Karak; Colette Hanna; Joelle Antoun; Dolly Nasr
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

6.  Ablation of perivascular hepatic malignant tumors with irreversible electroporation.

Authors:  T Peter Kingham; Ami M Karkar; Michael I D'Angelica; Peter J Allen; Ronald P Dematteo; George I Getrajdman; Constantinos T Sofocleous; Stephen B Solomon; William R Jarnagin; Yuman Fong
Journal:  J Am Coll Surg       Date:  2012-06-16       Impact factor: 6.113

7.  Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.

Authors:  H J Scheffer; K Nielsen; A A J M van Tilborg; J M Vieveen; R A Bouwman; G Kazemier; H W M Niessen; S Meijer; C van Kuijk; M P van den Tol; M R Meijerink
Journal:  Eur Radiol       Date:  2014-06-18       Impact factor: 5.315

8.  Vessel patency post irreversible electroporation.

Authors:  Govindarajan Narayanan; Shivank Bhatia; Ana Echenique; Rekha Suthar; Katuzka Barbery; Jose Yrizarry
Journal:  Cardiovasc Intervent Radiol       Date:  2014-09-12       Impact factor: 2.740

9.  Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival.

Authors:  Robert C G Martin; Kelli McFarland; Susan Ellis; Vic Velanovich
Journal:  Ann Surg Oncol       Date:  2012-11-06       Impact factor: 5.344

10.  Percutaneous ablation of peribiliary tumors with irreversible electroporation.

Authors:  Mikhail T Silk; Thomas Wimmer; Kyungmouk S Lee; Govindarajan Srimathveeravalli; Karren T Brown; Peter T Kingham; Yuman Fong; Jeremy C Durack; Constantinos T Sofocleous; Stephen B Solomon
Journal:  J Vasc Interv Radiol       Date:  2013-11-18       Impact factor: 3.464

View more
  13 in total

Review 1.  New Approaches in Locoregional Therapies for Hepatocellular Carcinoma.

Authors:  Riccardo Memeo; Vito de Blasi; Zineb Cherkaoui; Ammar Dehlawi; Nicola De' Angelis; Tullio Piardi; Daniele Sommacale; Jacques Marescaux; Didier Mutter; Patrick Pessaux
Journal:  J Gastrointest Cancer       Date:  2016-09

Review 2.  Ablation of Intrahepatic Cholangiocarcinoma.

Authors:  Jennifer Sweeney; Nainesh Parikh; Ghassan El-Haddad; Bela Kis
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

Review 3.  NK Cell Adoptive Immunotherapy of Cancer: Evaluating Recognition Strategies and Overcoming Limitations.

Authors:  Carlos E Sanchez; Ehsan P Dowlati; Ashley E Geiger; Kajal Chaudhry; Matthew A Tovar; Catherine M Bollard; Conrad Russell Y Cruz
Journal:  Transplant Cell Ther       Date:  2020-09-29

4.  A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation.

Authors:  Jayanth S Shankara Narayanan; Partha Ray; Ibtehaj Naqvi; Rebekah White
Journal:  J Vis Exp       Date:  2018-06-08       Impact factor: 1.355

Review 5.  The role of interventional radiology in the treatment of patients with pancreatic cancer.

Authors:  Aycan Uysal; Emre Unal; Ali Devrim Karaosmanoglu; Ronald Arellano; Turkmen Turan Ciftci; Devrim Akinci; Okan Akhan
Journal:  Br J Radiol       Date:  2020-11-12       Impact factor: 3.039

6.  Pain Analysis in Patients with Pancreatic Carcinoma: Irreversible Electroporation versus Cryoablation.

Authors:  Jiannan Li; Shihou Sheng; Kai Zhang; Tongjun Liu
Journal:  Biomed Res Int       Date:  2016-12-15       Impact factor: 3.411

Review 7.  Irreversible Electroporation: A Novel Ultrasound-guided Modality for Non-thermal Tumor Ablation.

Authors:  Chih-Yang Hsiao; Kai-Wen Huang
Journal:  J Med Ultrasound       Date:  2017-10-06

Review 8.  Image-guided high-dose-rate brachytherapy of malignancies in various inner organs - technique, indications, and perspectives.

Authors:  Tina Bretschneider; Jens Ricke; Bernhard Gebauer; Florian Streitparth
Journal:  J Contemp Brachytherapy       Date:  2016-07-01

Review 9.  Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Authors:  Bela Kis; Ghassan El-Haddad; Rahul A Sheth; Nainesh S Parikh; Suvranu Ganguli; Paul B Shyn; Junsung Choi; Karen T Brown
Journal:  Cancer Control       Date:  2017 Jul-Sep       Impact factor: 3.302

10.  Transchondral access for irreversible electroporation of hepatocellular carcinoma.

Authors:  Mohamed Elboraey; Zlatko Devcic; Andrew R Lewis; Charles A Ritchie; Gregory T Frey; Ricardo Paz-Fumagalli; J Mark McKinney; Beau B Toskich
Journal:  Radiol Case Rep       Date:  2020-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.